STATEMENT: EMPOWER Patients Coalition on Prescription Drug Reform Act Passing Unanimously in the Florida Senate
Tallahassee, Fla. –The statement below, to be attributed to EMPOWER Patients coalition member and Executive Vice President and CEO of the Florida Pharmacy Association Helen Sairany, is being made in response to State Sen. Jason Brodeur’s (R-Lake Mary) SB 1550 – the “Prescription Drug Reform Act” – passing unanimously in the Senate Chamber today, Wed., April 19.
“Thank you to Sen. Brodeur and members of the Florida Senate for passing SB 1550. This is a momentous milestone for both patients and independent and community pharmacists, as we are now one step closer to implementing meaningful pharmacy benefit manager reform in Florida. The EMPOWER Patients coalition remains cautiously optimistic that this landmark legislation will continue to receive favorable support until it becomes law, codifying long-overdue provisions to rein in predatory PBMs, as well as life-changing consumer and small business protections.”
For more information about EMPOWER Patients, please click here.
About EMPOWER Patients
The EMPOWER Patients coalition formed in 2020 to support policies that empower patients to take back control of their health care, increase access to affordable medication, restore the patient/pharmacist relationship, and drastically scale back the role of pharmacy benefit managers (PBMs) in the prescription drug supply chain. EMPOWER Patients is comprised of the American Pharmacy Cooperative, Inc., Aspire Health Pharmacy Services, Florida Independent Pharmacy Network, Florida Pharmacy Association, National Community Pharmacists Association, Pharmacy Provider Services Corporation, Walgreens, and hundreds of patients and independent and community pharmacists and pharmacies across Florida.